COST OF LONG-ACTING RISPERIDONE INJECTION VERSUS LONG-ACTING PALIPERIDONE PALMITATE IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA

被引：0
|
作者：
Omelyanovsky, V [1 ]
Avxentyeva, M. [1 ]
Ivakhnenko, O. [1 ]
Khailov, P. [1 ]
Tsfasman, F. M. [1 ]
Krysanov, I [1 ]
Zorin, N. [1 ]
机构：
[1] Russian Natl Res Med Univ, Res Ctr Clin & Econ Evaluat & Pharmacoecon, Moscow, Russia
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A338 / A338
页数：1
相关论文
共 50 条
  • [21] A randomized, double-blind study of paliperidone palmitate and risperidone long-acting therapy in schizophrenia
    Pandina, G.
    Lane, R.
    Gopal, S.
    Gassmann-Mayer, C.
    Hough, D.
    Remmerie, B.
    Simpson, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S481 - S482
  • [22] A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia
    Pandina, Gahan
    Lane, Rosanne
    Gopal, Srihari
    Gassmann-Mayer, Cristiana
    Hough, David
    Remmerie, Bart
    Simpson, George
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (01) : 218 - 226
  • [23] Hospitalizations and economic analysis in psychotic patients with paliperidone palmitate long-acting injection
    Mesones-Peral, Jesus E.
    Gurillo-Munoz, Pedro
    Paz Sanchez-Sicilia, Mari
    Miller, Adam
    Grinant-Fernandez, Alejandra
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2017, 10 (01): : 33 - 37
  • [24] Long term benefits of treatment with risperidone long-acting injection in patients with schizophrenia
    Turner, MS
    Urquhart, E
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S399 - S399
  • [25] Preparation, in vitro and in vivo Evaluation of Paliperidone Palmitate Long-acting Injection
    Wang, Dan
    Shi, Junfeng
    Zhang, Hui
    Zheng, Aiping
    Wang, Ting
    Chinese Journal of Pharmaceuticals, 2023, 54 (06) : 902 - 908
  • [26] The effects of risperidone long-acting injection versus paliperidone palmitate on cognitive and social function in schizophrenia - an open pilot randomised controlled trial
    Koshikawa, Y.
    Takekita, Y.
    Kato, M.
    Sakai, S.
    Onohara, A.
    Sunada, N.
    Nishida, K.
    Yoshimura, M.
    Fabbri, C.
    Serretti, A.
    Kinoshita, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S500 - S501
  • [27] Paliperidone palmitate long-acting injection in adolescents: report of two cases
    Fabrega Ribera, M.
    Garcia Chulbi, S.
    Sugranyes Ernest, G.
    Baeza Pertegaz, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S606 - S607
  • [28] Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA
    Edwards, NC
    Locklear, JC
    Rupnow, MFT
    Diamond, RJ
    PHARMACOECONOMICS, 2005, 23 (Suppl 1) : 75 - 89
  • [29] Risperidone long-acting injection in the treatment of recently versus longer diagnosed patients with schizophrenia
    Lambert, T.
    Olivares, J. M.
    Tuma, I.
    Peuskens, J.
    Pecenak, J.
    bij de Weg, H.
    Eriksson, L.
    Bork, B.
    Povey, M.
    Zhao, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S434 - S434
  • [30] Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA
    Natalie Christine Edwards
    Julie C. Locklear
    Marcia F. T. Rupnow
    Ronald J. Diamond
    PharmacoEconomics, 2005, 23 : 75 - 89
12345